T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia
Open Access
- 15 May 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 107 (10) , 3983-3991
- https://doi.org/10.1182/blood-2005-10-4201
Abstract
In aplastic anemia, immune destruction of hematopoietic cells results in bone marrow failure. Type 1 cytokines, especially IFN-γ, have been implicated in the pathophysiology of T-cell–mediated, Fas-mediated stem cell apoptosis of hematopoietic cells. Here, we show that the transcription factor T-bet (T-box expressed in T cells) is increased in T cells from patients with aplastic anemia. Patients' T-bet bound directly to the proximal site of the IFN-γ promoter without any prior stimulation, in contrast to healthy controls. Increased levels of Itk kinase participated in T-bet up-regulation and active transcription of the IFN-γ gene observed in these patients. Blocking PKC-θ, a kinase that lies downstream of Itk kinase, decreased T-bet protein and IFN-γ intracellular levels. These data suggest that the increased IFN-γ levels observed in aplastic anemia patients are the result of active transcription of the IFN-γ gene by T-bet. Blocking the transcription of the IFN-γ gene with kinase inhibitors might lead to the development of novel therapeutic agents for patients with aplastic anemia and other autoimmune diseases.Keywords
This publication has 58 references indexed in Scilit:
- The promise of molecular targeted therapies: Protein kinase inhibitors in the treatment of cutaneous malignanciesPublished by Elsevier ,2005
- New IL-12-family members: IL-23 and IL-27, cytokines with divergent functionsNature Reviews Immunology, 2005
- Identification of a novel type 1 diabetes susceptibility gene, T-betHuman Genetics, 2004
- Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patientsBritish Journal of Haematology, 2003
- T-bet as a possible therapeutic target in autoimmune diseaseEmerging Therapeutic Targets, 2002
- Hlx is induced by and genetically interacts with T-bet to promote heritable TH1 gene inductionNature Immunology, 2002
- Protein kinase Cθ: a new essential superstar on the T-cell stageImmunology Today, 2000
- Signaling and Transcription in T Helper DevelopmentAnnual Review of Immunology, 2000
- Complex Complexes: Signaling at the TCRImmunity, 1996
- Circulating Activated Suppressor T Lymphocytes in Aplastic AnemiaNew England Journal of Medicine, 1985